logo-loader
viewG Medical Innovations Holdings Ltd

G Medical Innovations a leading gainer on news of proposed Hong Kong listing of Chinese subsidiary

The shares were up 60% to an intra-day high of 29.7 cents on volume of more than 4.5 million.

ASX chart with arrow pointing up
The company specialises in mobile and e-health solutions and services

G Medical Innovations Holdings Ltd (ASX:GMV) is a leading ASX gainer on news of its intention to list its Chinese subsidiary on the main board of The Stock Exchange of Hong Kong Limited.

Shares were up 60% to an intra-day high of 29.7 cents on strong volume of more than 4.5 million.

Global investment bank engaged

The company has engaged global investment bank, UOB Kay Hian (Hong Kong) Ltd, as advisers for the listing of Guangzhou Yimei Innovative Medical Science and Technology Co Ltd (GYIMSTC).

Under the proposed listing, GYIMSTC would spin off from G Medical, with the ASX-listed company to retain not less than a 50% ownership stake.

The parent company currently holds 70% of GYIMSTC.

Intended listing in six to nine months

All parties are working towards a listing within the next six to nine months.

GYIMSTC oversees China-based manufacturing for G Medical, ensures all local certifications are met and has worked to build a strong relationship with the China Food and Drug Administration (CFDA).

It was the first company in 2018 to be granted acceptance to the Green Channel expedited Guangdong Provincial CFDA regulatory approval process.

Proven performer in China

This process was successfully applied to G Medical’s Prizma Medical Smartphone Case and will play a crucial role in the global commercialisation of this product.

Future innovative medical solutions in the development pipeline should also benefit from this process.

Funds raised from the listing will provide substantial working capital and fuel the research and development of innovative mobile health solutions and enable continued investment into state-of-the-art manufacturing facilities.

G Medical specialises in innovative next-generation mobile and e-health solutions and services using its suite of devices and software solutions with a view to driving multiple and recurring revenue streams.

Quick facts: G Medical Innovations Holdings Ltd

Price: 0.079 AUD

ASX:GMV
Market: ASX
Market Cap: $32.15 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of G Medical Innovations Holdings Ltd named herein, including the promotion by the Company of G Medical Innovations Holdings Ltd in any Content on...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Australian e-health company G Medical Innovations eyes Nasdaq listing

G Medical Innovations Holdings Ltd (ASX:GMV) CEO Yacov Geva sits down with Proactive Investors' Christine Corrado in New York to update investors on the mobile and e-health company's move to list on the Nasdaq. Geva says the company, which specializes in software and devices that aim to...

on 16/10/18

2 min read